B

BlueMTec Co Ltd
KOSDAQ:439580

Watchlist Manager
BlueMTec Co Ltd
KOSDAQ:439580
Watchlist
Price: 3 450 KRW 2.22%
Market Cap: ₩116.8B

BlueMTec Co Ltd
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

BlueMTec Co Ltd
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
B
BlueMTec Co Ltd
KOSDAQ:439580
Other Items
-₩13.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Chorokbaem Healthcare Co Ltd
KRX:118000
Other Items
-₩19.4B
CAGR 3-Years
N/A
CAGR 5-Years
8%
CAGR 10-Years
N/A
W
WSI Co Ltd
KOSDAQ:299170
Other Items
-₩19.5B
CAGR 3-Years
-228%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
Wonik Co Ltd
KOSDAQ:032940
Other Items
₩413.8m
CAGR 3-Years
N/A
CAGR 5-Years
-14%
CAGR 10-Years
N/A
H
HLB Life Science Co Ltd
KOSDAQ:067630
Other Items
-₩9B
CAGR 3-Years
45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

BlueMTec Co Ltd
Glance View

Market Cap
116.8B KRW
Industry
Health Care

BlueMtec Co., Ltd. engages in the distribution of pharmaceutical for clinics, online shopping, business to business platform, website production, and online marketing. The company is headquartered in Pyeongtaek, Gyeonggi-Do and currently employs 87 full-time employees. The company went IPO on 2023-12-13. The firm also engages in other e-commerce, Website and application production, advertising agency, and service businesses.

Intrinsic Value
4 129.22 KRW
Undervaluation 16%
Intrinsic Value
Price
B

See Also

What is BlueMTec Co Ltd's Other Items?
Other Items
-13.4B KRW

Based on the financial report for Dec 31, 2024, BlueMTec Co Ltd's Other Items amounts to -13.4B KRW.

What is BlueMTec Co Ltd's Other Items growth rate?
Other Items CAGR 1Y
-349%

Over the last year, the Other Items growth was -349%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett